Cargando…
Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin
Cisplatin is an essential chemotherapeutic drug in the treatment of many cancers. Its use, however, is limited by the development of resistance in many tumors. The ability to re-sensitize resistant tumors could significantly strengthen cisplatin therapy in patients. Caenorhabditis elegans is a suita...
Autores principales: | Natarajan, Balasubramanian, Gaur, Rahul, Hemmingsson, Oskar, Kao, Gautam, Naredi, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670465/ https://www.ncbi.nlm.nih.gov/pubmed/24058864 http://dx.doi.org/10.4161/worm.24059 |
Ejemplares similares
-
A proinsulin-dependent interaction between ENPL-1 and ASNA-1 in neurons is required to maintain insulin secretion in C. elegans
por: Podraza-Farhanieh, Agnieszka, et al.
Publicado: (2023) -
Alternative redox forms of ASNA-1 separate insulin signaling from tail-anchored protein targeting and cisplatin resistance in C. elegans
por: Raj, Dorota, et al.
Publicado: (2021) -
A Directed RNAi Screen Based on Larval Growth Arrest Reveals New Modifiers of C. elegans Insulin Signaling
por: Billing, Ola, et al.
Publicado: (2012) -
Cisplatin toxicity is counteracted by the activation of the p38/ATF-7 signaling pathway in post-mitotic C. elegans
por: Raj, Dorota, et al.
Publicado: (2023) -
Mitochondrial Function Is Required for Secretion of DAF-28/Insulin in C. elegans
por: Billing, Ola, et al.
Publicado: (2011)